Concepedia

The WNT receptor ROR2 drives the interaction of multiple myeloma cells with the microenvironment through AKT activation

Michela Frenquelli, Nicoletta Caridi, Elena Antonini, Federica Storti, Valentina Viganò, Marco Gaviraghi, Manuela Occhionorelli, Silvia Bianchessi, Lucia Bongiovanni, Antonello E. Spinelli,

Leukemia · 2019 · 43 citations · 33 references

DOIFull text

Open access

Concepts

References

33

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

, , +11

The molecular classification of multiple myeloma

Fenghuang Zhan, Yongsheng Huang, Simona Colla et al. · Blood · 2006 · 1.1K citations · Full text

, , +14

Preclinical activity, pharmacodynamic, and pharmacokinetic properties of a selective HDAC6 inhibitor, ACY-1215, in combination with bortezomib in multiple myeloma

Loredana Santo, Teru Hideshima, Andrew L. Kung et al. · Blood · 2012 · 601 citations · Full text

, , +15

The phosphoinositide 3′-kinase delta inhibitor, CAL-101, inhibits B-cell receptor signaling and chemokine networks in chronic lymphocytic leukemia

Julia Hoellenriegel, Sarah Meadows, Mariela Sivina et al. · Blood · 2011 · 548 citations · Full text

, , +15

Expression of Wnt-5a Is Correlated with Aggressiveness of Gastric Cancer by Stimulating Cell Migration and Invasion

Manabu Kurayoshi, Naohide Oue, Hideki Yamamoto et al. · Cancer Research · 2006 · 458 citations · Full text

, , +17